Prostate Cancer

Latest News

CMS issues category 1 CPT codes for TULSA procedure
CMS issues category 1 CPT codes for TULSA procedure

July 11th 2024

All 3 codes for the procedure will become effective on January 1, 2025.

Merck obtains exclusive global rights to CYP11A1 inhibitor in mCRPC
Merck obtains exclusive global rights to CYP11A1 inhibitor in mCRPC

July 3rd 2024

FDA grants fast track designation to 225Ac-FL-020 in mCRPC
FDA grants fast track designation to 225Ac-FL-020 in mCRPC

July 3rd 2024

FDA awards fast track designation to SYNC-T SV-102 in mCRPC
FDA awards fast track designation to SYNC-T SV-102 in mCRPC

July 1st 2024

PSA screening may miss prostate cancer among transgender women, data suggests
PSA screening may miss prostate cancer among transgender women, data suggests

June 27th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.